Purchases and Sales Made in Q4 2023 in Janux Therapeutics, Inc. (JANX)
This table provides information about the institutional ownership of Janux Therapeutics, Inc. (JANX) during Q4 2023. The information is specifically focused on institutions that hold shares of Janux Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-14.4K- 17.54% |
$83.9K - $168K
|
67.4K
$3.79M
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-66.4K- 48.02% |
$388K - $777K
|
71.9K
$4.03M
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-131K- 88.07% |
$766K - $1.53M
|
17.7K
$996K
|
|
|
Feb 14, 2024
Q4 2023
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-136K- 6.58% |
$796K - $1.59M
|
1.93M
$108M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-311K- 9.06% |
$1.82M - $3.64M
|
3.12M
$175M
|